The expression and function of miRNA-106 in pediatric osteosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Osteosarcoma is a primary bone malignancy with a high propensity for metastasis.
• MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
• The specific role of miR-106b in osteosarcoma remains to be fully elucidated.

Purpose of the Study:

• To investigate the expression levels of miR-106b in osteosarcoma tissues.
• To determine the biological functions of miR-106b in osteosarcoma cell proliferation, cell cycle, invasion, and metastasis.
• To explore the underlying molecular mechanisms involving the PI3K/AKT signaling pathway.

Main Methods:

• Real-time PCR was used to quantify miR-106b expression in osteosarcoma and adjacent normal tissues from 54 patients.
• In vitro functional assays, including CCK-8, flow cytometry, and Transwell assays, were performed on U2-OS cells transfected with miR-106b inhibitors.
• Western blot analysis was employed to assess the activity of the PI3K/AKT signaling pathway.

Main Results:

• miR-106b expression was significantly elevated in osteosarcoma tissues compared to para-carcinoma tissues.
• Elevated miR-106b levels correlated positively with lung metastasis and advanced clinical stages.
• Inhibition of miR-106b suppressed osteosarcoma cell proliferation, invasion, migration, and induced G1 cell cycle arrest.
• Downregulation of miR-106b led to reduced AKT phosphorylation and PI3Kp100 expression, indicating PI3K/AKT pathway inhibition.

Conclusions:

• miR-106b is upregulated in osteosarcoma and serves as a potential biomarker for metastasis and disease stage.
• miR-106b acts as an oncogene, promoting osteosarcoma cell proliferation and invasion.
• The oncogenic function of miR-106b is mediated, at least in part, through the activation of the PI3K/AKT signaling pathway.